Skye Bioscience, Inc. (SKYE)
1.22
+0.01
(+0.83%)
USD |
NASDAQ |
Dec 09, 12:48
Skye Bioscience Shareholders Equity (Quarterly): 32.84M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | 242.22M |
| Theravance Biopharma, Inc. | 232.68M |
| Viking Therapeutics, Inc. | 713.03M |
| FibroGen, Inc. | -17.03M |
| Myomo, Inc. | 14.63M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 41.32M |
| Total Liabilities (Quarterly) | 8.488M |
| Debt to Equity Ratio | 0.0098 |
| Current Ratio | 4.771 |
| Net Debt Paydown Yield | 0.78% |